Literature DB >> 29475872

Endorsing performance measures is a matter of trust.

Dharmvir S Jaswal1, Charles Natanson1, Peter Q Eichacker2.   

Abstract

Mesh:

Year:  2018        PMID: 29475872      PMCID: PMC6889976          DOI: 10.1136/bmj.k703

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  22 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  ACP Journal Club: in early septic shock, early goal-directed therapy did not reduce 90-day mortality.

Authors:  Dharmvir S Jaswal; Peter Q Eichacker
Journal:  Ann Intern Med       Date:  2015-08-18       Impact factor: 25.391

3.  The Quality and Outcomes Framework: what have you done to yourselves?

Authors:  Dee Mangin; Les Toop
Journal:  Br J Gen Pract       Date:  2007-06       Impact factor: 5.386

Review 4.  Pay for performance in the inpatient sector: A review of 34 P4P programs in 14 OECD countries.

Authors:  Ricarda Milstein; Jonas Schreyoegg
Journal:  Health Policy       Date:  2016-09-20       Impact factor: 2.980

5.  Early goal-directed therapy: on terminal life support?

Authors:  Paul E Marik; Joseph Varon
Journal:  Am J Emerg Med       Date:  2010-02       Impact factor: 2.469

6.  Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge.

Authors:  David Osman; Christophe Ridel; Patrick Ray; Xavier Monnet; Nadia Anguel; Christian Richard; Jean-Louis Teboul
Journal:  Crit Care Med       Date:  2007-01       Impact factor: 7.598

7.  Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

Authors:  R Phillip Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven A Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

8.  Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department.

Authors:  Stephen Trzeciak; R Phillip Dellinger; Nicole L Abate; Robert M Cowan; Mary Stauss; J Hope Kilgannon; Sergio Zanotti; Joseph E Parrillo
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

Review 9.  Do Health Care Delivery System Reforms Improve Value? The Jury Is Still Out.

Authors:  Deborah Korenstein; Kevin Duan; Manuel J Diaz; Rosa Ahn; Salomeh Keyhani
Journal:  Med Care       Date:  2016-01       Impact factor: 2.983

10.  The incidence of low venous oxygen saturation on admission to the intensive care unit: a multi-center observational study in The Netherlands.

Authors:  Paul A van Beest; Jorrit J Hofstra; Marcus J Schultz; E C Boerma; Peter E Spronk; Michael A Kuiper
Journal:  Crit Care       Date:  2008-03-04       Impact factor: 9.097

View more
  4 in total

Review 1.  Driving blind: instituting SEP-1 without high quality outcomes data.

Authors:  Jeffrey Wang; Jeffrey R Strich; Willard N Applefeld; Junfeng Sun; Xizhong Cui; Charles Natanson; Peter Q Eichacker
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

2.  Association of Registered Nurse Staffing With Mortality Risk of Medicare Beneficiaries Hospitalized With Sepsis.

Authors:  Jeannie P Cimiotti; Edmund R Becker; Yin Li; Douglas M Sloane; Scott K Fridkin; Anna Beth West; Linda H Aiken
Journal:  JAMA Health Forum       Date:  2022-05-27

3.  Erratum to driving blind: instituting SEP-1 without high quality outcomes data.

Authors: 
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

4.  Conflicts of interest and the patient-doctor covenant.

Authors:  Martin J Tobin
Journal:  Intensive Care Med       Date:  2018-07-06       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.